These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15560649)

  • 21. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
    Piscopo JA
    NIDA Res Monogr; 1993; 131():249-59. PubMed ID: 8105384
    [No Abstract]   [Full Text] [Related]  

  • 23. Making it easier to read prescriptions.
    Farley D
    FDA Consum; 1995; 29(6):25-7. PubMed ID: 10143448
    [No Abstract]   [Full Text] [Related]  

  • 24. The prescription of controlled substances: what's right and what's wrong.
    Cohen S
    NIDA Res Monogr; 1979; 27():11-6. PubMed ID: 44892
    [No Abstract]   [Full Text] [Related]  

  • 25. Prescription Drug Monitoring Program.
    CDA Practice Support
    J Calif Dent Assoc; 2014 Jul; 42(7):482-3. PubMed ID: 25076632
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary in response to Paulozzi et al.: prescription drug abuse and safe pain management.
    Fishman SM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):628-31. PubMed ID: 16862601
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of medications revisited.
    Alt HA
    Tex Med; 1988 Nov; 84(11):66-70. PubMed ID: 3238618
    [No Abstract]   [Full Text] [Related]  

  • 29. New law preserves physician's rights to distribute drug samples.
    Mossinghoff GJ
    Colo Med; 1988 Oct; 85(18):392. PubMed ID: 3224496
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug samples--there is no free lunch! Minimize your risks and meet your regulatory responsibilities.
    Freeman J
    Iowa Med; 2005; 95(5):10-1. PubMed ID: 16270612
    [No Abstract]   [Full Text] [Related]  

  • 31. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doctors with multi-state practices beware: new DEA regulation could affect you.
    Ball FR
    J Med Pract Manage; 2007; 23(2):104-5. PubMed ID: 17974088
    [No Abstract]   [Full Text] [Related]  

  • 33. Dispensing, prescribing and administering drugs: what you need to know.
    MDA Special Committee on Care and Well Being
    J Mich Dent Assoc; 2010 Mar; 92(3):46-50. PubMed ID: 20391816
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines for prescribers of controlled substances.
    Wis Med J; 1981 Jun; 80(6):53-4. PubMed ID: 7257443
    [No Abstract]   [Full Text] [Related]  

  • 35. Wanted: a public health approach to prescription opioid abuse and diversion.
    Joranson DE; Gilson AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
    [No Abstract]   [Full Text] [Related]  

  • 36. Perspective of the American Pharmaceutical Association.
    Webb CE
    NIDA Res Monogr; 1993; 131():235-8. PubMed ID: 8413535
    [No Abstract]   [Full Text] [Related]  

  • 37. State adopts new prescription drug rules.
    J Mich Dent Assoc; 1998 Sep; 80(7):7-8. PubMed ID: 9874605
    [No Abstract]   [Full Text] [Related]  

  • 38. A prescription for your well being.
    Vold M
    CDS Rev; 2004; 97(4):32-3. PubMed ID: 15378967
    [No Abstract]   [Full Text] [Related]  

  • 39. Too many drugs?
    Halberstam MJ
    Forum Med; 1979 Mar; 2(3):170-6 concl. PubMed ID: 10316794
    [No Abstract]   [Full Text] [Related]  

  • 40. The DEA proposes schedule II substance rule.
    Buchanan BL
    WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.